IXICO PLC

IXICO plc provides data analytics services to the biopharmaceutical industry across the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. Its offerings include collection, analysis, management, and reporting of clinical study data, with a focus on neurological diseases, as well as imaging contract research organization solutions such as imaging biomarkers (radiological reads, volumetric MRI, PET, SPECT, advanced MRI), trial management, data analytics, post-marketing surveillance, clinical diagnostics, and consultancy. The company also provides the IXICO platform, an AI-enabled technology platform for neuroimaging data management and analysis. Its services support therapeutic areas including Alzheimer's, Huntington's, Multiple Sclerosis, and Parkinson's diseases, along with other rare neurological diseases, demyelinating disorders, and Parkinsonian disorders. IXICO collaborates with Medidata to create a neuroimaging clinical trials platform and is based in London, the United Kingdom.